Back

Real-world experience with sodium-glucose cotransporter 2 inhibitors in adults with fontan circulatory failure

10 April 2026 (18:34 - 18:42)
Organised by: Logo
Seminar Presentation Part of: Best abstracts presentations and Awards Adult Congenital Heart Disease (ACHD) Open Access EuroACHD 2026 WG on Adult Congenital Heart Disease

4 More presentations in this session

Presentation thumbnail
Machine learning-assisted mortality risk stratification in Eisenmenger syndrome
Slides
Presentation thumbnail
Transcatheter edge-to-edge repair of tricuspid valve regurgitation in systemic right ventricle: Echocardiographic outcome
Slides
Presentation thumbnail
Portal vein flow pulsatility in fontan patients: a comparison of lateral tunnel with extracardiac conduit
Slides
Presentation thumbnail
The Hidden Burden and Complex Determinants of Congenital Heart Disease in Afghanistan: An Integrated Analysis
Slides

Access the full session

Session thumbnail
Best abstracts presentations and Awards

The Event

Event poster

EuroACHD 2026

10 April 2026 18:34 CET
You may be interested in
thumbnail
Congress Presentation
Sodium-glucose cotransporter 2 inhibitors are safe and potentially beneficial for the treatment of heart failure in adult congenital heart disease
22 May 2023
thumbnail
Congress Presentation
Outcomes and management of Haemoptysis in the Fontan population
31 August 2024
thumbnail
Congress Session
Advances in medical therapy in heart failure
20 May 2025
thumbnail
Congress Presentation
Patients with Fontan circulation beyond the fourth decade of life
31 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources